Acral lentiginous melanoma: clinicopathological characteristics and survival outcomes in the US National Cancer Database 2004-2016
- PMID: 32407556
- DOI: 10.1111/bjd.19211
Acral lentiginous melanoma: clinicopathological characteristics and survival outcomes in the US National Cancer Database 2004-2016
References
-
- Bradford PT, Goldstein AM, McMaster ML, Tucker MA. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005. Arch Dermatol 2009; 145:427-34.
-
- Egger ME, McMasters KM, Callender GG et al. Unique prognostic factors in acral lentiginous melanoma. Am J Surg 2012; 204:874-9; discussion 879-80.
-
- Teramoto Y, Keim U, Gesierich A et al. Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German Central Malignant Melanoma Registry (CMMR) in 2050 patients. Br J Dermatol 2018; 178:443-51.
-
- Elias ML, Behbahani S, Maddukuri S et al. Prolonged overall survival following metastasectomy in stage IV melanoma. J Eur Acad Dermatol Venereol 2019; 33:1719-25.
-
- Howard MD, Xie C, Wee E et al. Acral lentiginous melanoma: differences in survival compared with other subtypes. Br J Dermatol 2020; 182:1056-7.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
